Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients

Cancer

Volumn 79, Issue 9, 1997, Pages 1664-1670

  Litle, Virginia R ^a,b   Warren, Robert S ^a,b   Moore II, Dan ^b   Pallavicini, Maria G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

fluorescent in situ hybridization; immunocytochemistry; micrometastases; recurrent disease

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; CANCER SURGERY; CELL LABELING; CELL SUBPOPULATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIVER METASTASIS; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY, NEEDLE; BONE MARROW; COLORECTAL NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0030911977     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970501)79:9<1664::AID-CNCR5>3.0.CO;2-C     Document Type: Article

References (21)

1. Turk PS, Wanebo HJ. Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer 1993;71(12 Suppl):4267-77.
2. Cote RJ, Rosen PP, Hakes TB, Sedira M, Bazinet M, Kinne DW, et al. Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 1988;12(5):333-40.
3. Mansi JL, Berger U, McDonnell T, Pople A, Rayter Z, Gazet JC, et al. The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 1989;7(4):445-9.
4. Pantel K, Schlimok G, Braun S, Passlick B, Karg O, Thetter O, et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 1993;85(17):1419-24.
5. Pantel K, Schlimock G, Angstwurm M, Weckermann D, Schmaus W, Gath H, et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematotherapy 1994;3:165-73.
6. Lindemann F, Schlimock G, Dirschedl P, Witte J, Riethmuller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992; 340:685-9.
7. Schlimok G, Funke I, Bock B, Schweiberer B, Witte J, Riethmuller G. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 1990;8:831-7.
8. Schlimok G, Funke I, Holzmann B, Gottlinger G, Schmidt G, Hauser H, et al. Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci USA 1987;84:8672-6.
9. Pantel K, Izbicki JR, Angstwurm M, Braun S, Passlick B, Karg O, et al. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 1993;53:1027-31.
10. Seidal T. Immunoreactivity to cytokeratins in non-epithelial cells in deep gastric ulcer. APMIS 1993;101:607-13.
11. Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 1990;111:567-80.
12. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140(2):427-47.
13. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71(2):278-81.
14. Litle VR, Lockett SJ, Pallavicin MG. Genotype/phenotype analyses of low frequency tumor cells using computerized image microscopy. Cytometry 1996;23:344-9.
15. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986;83:2934-8.
16. Gray JW, Pinkel D. Molecular cytogenetics in human cancer diagnosis. Cancer 1992;69(Suppl 6):1536-42.
17. Johnson GD, Nogueria JGM. A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods 1981;43:349-50.
18. Kuo W-L, Tenjin H, Segraves R, Pinkel D, Golbus MS, Gray J. Detection of aneuploidy involving chromosomes 13, 18 or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. Am J Hum Genet 1991;49:112-9.
19. Reichmann A, Levin B, Martin P. Human large-bowel cancer: correlation of clinical and histopathological features with banded chromosomes. Int J Cancer 1982;29:625-9.
20. Ochi H, Takeuchi J, Holyoke D, Sandberg AA. Possible specific chromosome changes in large bowel cancer. Cancer Genet Cytogenet 1983;10:121-2.
21. Lisitsyn NA, Lisitsina NM, Dalbagni G, Barker P, Sanchez CA, Gnarra J, et al. Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci USA 1995;92(1):151-5.